The longevity shift: strategic implications of the longevity medicine revolution - Ipsos
The longevity shift: strategic implications of the longevity medicine revolution - Ipsos

The longevity shift: strategic implications of the longevity medicine revolution

Turn longevity from trend to strategy: where should pharma play - and how to win?

Longevity is emerging as one of the most dynamic frontiers in healthcare innovation. In 2025, longevity’s not just about living longer; it’s about preserving vitality, function and independence - creating new strategic options for portfolios and go to market.

This new point of view maps the emergence of longevity medicine, the strategic implications and the growing recognition that longevity may become a defining theme in the future of medicine.
 

The author(s)

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.